Etodroxizine

This classification denotes a sedative and hypnotic with the molecular formula C23H31ClN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CI1S3XAK7O, chemically known as 3,6-dioxaoctanol, 8-(4-(4-chlorophenylphenylmethyl)piperazinyl)- but generally known as etodroxizine, which bears US NIH Compound Identifier 63345. European Medicines Agency schedules Etodroxizine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07317MIG. The term ETODROXIZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). ETODROXIZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule etodroxizine under HS 29335995 and SITC 51576. As of Q4 2014, ETODROXIZINE remains the US FDA Preferred Term for this commodity. Etodroxizine bears US NLM identifiers UMLS ID C0059866 and NCI Concept Code C65585. SMILES: CLC1CCC(C(N2CCN(CC2)CCOCCOCCO)C2CCCCC2)CC1.